Recent News News

Interim Survival Data from Phase 3 Trial of DCVax®-L for Glioblastoma Reported

(May 30, 2018)

Northwest Biotherapeutics, developer of DCVax® personalized immune therapies for solid tumor cancers, announced today the publication of interim blinded survival data from its Phase 3 clinical trial... Continue Reading


Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit

(May 29, 2018)

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at a major research meeting next month. Collaborators... Continue Reading


FDA Approves First non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults

(May 24, 2018)

Encouraging more widespread innovation and development of safe and effective treatments for opioid use disorder remains top agency priority The U.S. Food and Drug Administration today approved Lucemyra... Continue Reading


FDA Approves Aliqopa for Relapsed Follicular Lymphoma

(May 23, 2018)

The U.S. Food and Drug Administration (FDA) granted accelerated approval to Aliqopa® (copanlisib), a novel precision cancer medicine that inhibits phosphatidylinositol 3-kinase (PI3K), for the treatment... Continue Reading


FDA Approves Kymriah for Treatment of Relapsed or Refractory Large B-Cell Lymphoma

(May 21, 2018)

On May 1, 2018, the United States Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel), a CD19-directed genetically modified autologous T-cell immunotherapy, for treatment of adult patients... Continue Reading


FDA Approves Aimovig, A Novel Preventive Treatment for Migraine Headaches

(May 21, 2018)

According to Dr. Jessica Ailani, MD, associate professor of neurology at MedStar’s Georgetown University Hospital and director of the MedStar Georgetown Headache Center, migraines affect over 36 million... Continue Reading


May Is National Skin Cancer Detection and Prevention Month

(May 18, 2018)

Sun Valley, ID —OMNI Health  (OMNI) announces the launch of skin cancer programs for national skin cancer detection and prevention month. As the month of May brings skin cancer into focus, it’s time... Continue Reading


PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer

(May 16, 2018)

CancerConnect News: The combination of a PARP inhibitor and a checkpoint inhibitor appears promising as treatment for patients with ovarian cancer, according to results of a clinical study reported at... Continue Reading


What is a Venous Access Device and What Types are Used for Cancer Patients?

(May 9, 2018)

A venous access device (VAD) is a surgically implanted device that provides long-term access to a major vein. A VAD can be useful for patients undergoing systemic treatment with precision cancer medicines... Continue Reading


Smoking and Cancer: Understand the Risk and What You Can Do to Control It

(May 8, 2018)

CancerConnect News: Smoking tobacco cigarettes is responsible for drastically increasing the risk of the developing lung cancer— the number-one cause of cancer-related deaths in the U.S—as well as... Continue Reading


« Previous PageNext Page »